gastric juice protein raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-05-06 and is reviewed periodically as new material appears.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
Quality assessment rests on two separate questions: whether the chain is the intended one, and how much of the sample is that chain. Reverse-phase high-performance liquid chromatography with ultraviolet detection is the standard purity measurement, while mass spectrometry confirms identity through the observed molecular mass. Amino acid analysis and sequence verification provide further checks. A reported purity percentage describes the proportion of the sample represented by the main peak, not the amount of peptide by mass, since counter-ions and water make up part of any lyophilized lot.
In its usual supplied form, the peptide is a white to off-white lyophilized powder that dissolves readily in water and in aqueous buffers. Powder keeps far longer than solution, so material is normally shipped and stored dry, then dissolved only when needed. Once in solution, the chain is subject to hydrolysis and the liquid supports microbial growth, and practical guidance generally treats the dissolved form as short-lived. Containers should stay sealed and desiccated, because the powder takes up moisture from air.
Long-term storage of the dry powder is typically described at minus twenty degrees Celsius or colder, while shorter holding periods may use ordinary refrigeration. Repeated warming and cooling cycles are discouraged because they stress the material and can promote aggregation or loss. Light exposure and residual moisture are both treated as avoidable sources of degradation, and working aliquots are often prepared to limit how many times a container is opened. Sealed vials with a desiccant are the usual container.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | Computed for the free peptide |
| Monoisotopic mass | Approximately 1419 Da | Reported values shift with counterion and hydration |
| Residue count | 15 amino acids | Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Origin | Fragment of human gastric juice protein | First described in early 1990s research reports |
| Common synonyms | BPC 157; PL 14736; bepecin | Naming varies across papers and catalogues |
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
In addition, proteins released from cells can impede protein C activation, for example eosinophil, which may explain thrombosis in hypereosinophilic heart disease. Protein C may be up-regulated by platelet factor 4. This cytokine is conjectured to improve activation of protein C by forming an electrostatic bridge from protein C's Gla domain to the glycosaminoglycan (GAG) domain of thrombomodulin, reducing the Michaelis constant (KM) for their reaction. In addition, Protein C is inhibited by protein C inhibitor.
The phase separation temperature (and hence, the cloud point) is dependent on polymer concentration. Therefore, temperature-composition diagrams are used to display thermoresponsive behavior over a wide range of concentrations. Phases separate into a polymer-poor and a polymer-rich phase. In strictly binary mixtures the composition of the coexisting phases can be determined by drawing tie-lines. However, since polymers display a molar mass distribution this straightforward approach may be insufficient. During the process of phase separation the polymer-rich phase can vitrify before equilibrium is reached. This depends on the glass transition temperature for each individual composition. It is convenient to add the glass transition curve to the phase diagram, although it is no real equilibrium. The intersection of the glass transition curve with the cloud point curve is called Berghmans point. In the case of UCST polymers, above the Berghmans point the phases separate into two liquid phases, below this point into a liquid polymer-poor phase and a vitrified polymer-rich phase. For LCST polymers the inverse behavior is observed.
=== Trump administration === On the same day of Powell's announcement, Trump denied having any knowledge of the investigation; White House Press Secretary Karoline Leavitt asserted that Trump did not order the Justice Department to investigate Powell. After suggesting at press conferences and social media posting in August and December 2025 that the administration would sue Powell due to the cost overruns, and after Powell announced that he was being targeted with an investigation, Trump said that Powell "either is incompetent or ... crooked" because of the cost overruns, and said that Powell will "be gone soon." However, Trump also said the investigation would not affect the timing of appointing a new Federal Reserve Chair as a successor to Powell. In an interview with Reuters on January 14, Trump said that he has no plans to fire Powell and that it was "too early" to say whether he would have legal grounds to remove Powell. Trump also dismissed concerns that diminished Federal Reserve independence would lead to higher inflation, asserting that "A president should have something to say" about monetary policy, while criticizing Republican Senators who may oppose his future Federal Reserve nominations due to the investigation, calling them disloyal. Secretary of the Treasury Scott Bessent has reportedly expressed concern that the investigation will cause volatility in the markets. While unnamed sources within the White House have suggested Federal Housing Finance Agency Director Bill Pulte may be behind the investigation of Powell, Pulte has publicly denied the allegations.
Matured quartz arenite within Vlamy Formation yield older and more diverse ages given by well-rounded detrital zircons, which may correlate to multiple sedimentary reworking events. On the contrary, Harmony Formation in the same region has younger and homogenous ages given by euhedral detrital zircons. These two formations illustrate the possibility of relating sedimentary maturity with resulting zircon ages, meaning that rounded and well-sorted sedimentary rocks (e.g. siltstone and mudstone) may have older and more diverse ages. Turbidites in Harts Pass Formation contain homogenous detrital zircons ages. On the other hand, fluvial Winthrop Formation in another strata of the same basin has various detrital zircon age populations. Comparing the vertical detrital zircon distribution within these two formations, one can expect a narrower age population of detrital zircons from rocks which are rapidly deposited, such as turbidites. Rocks that are gradually deposited (e.g. marine mudstone), however, have a greater chance and time to incorporate zircon sediments from different localities.
Expectations diminished as a result of numerous failed replications, the retraction of several previously reported positive replications, and the identification of methodological flaws and experimental errors in the original study. By late 1989, most scientists considered cold fusion claims dead, and cold fusion subsequently gained a reputation as pathological science. In 1989 the United States Department of Energy (DOE) concluded that the reported results of excess heat did not present convincing evidence of a useful source of energy and decided against allocating funding specifically for cold fusion. A second DOE review in 2004, which looked at new research, reached similar conclusions and did not result in DOE funding of cold fusion. Presently, since articles about cold fusion are rarely published in peer-reviewed mainstream scientific journals, they do not attract the level of scrutiny expected for mainstream scientific publications. Some interest in cold fusion has continued through the decades—for example, a Google-funded failed replication attempt was published in a 2019 issue of Nature. A small community of researchers continues to investigate it, often under the alternative designations low-energy nuclear reactions (LENR) or condensed matter nuclear science (CMNS).
Sources: en.wikipedia.org
=== Last meal === Lindow Man's last meal was preserved in his stomach and intestines and was analysed in some detail. It was hoped that investigations into the contents of the stomach would shed light on the contemporary diet, as was the case with Grauballe Man and Tollund Man in the 1950s. The analysis of the contents of the digestive system of bog bodies had become one of the principal endeavours of investigating such remains. Analysis of the grains present revealed Lindow Man's diet to be mostly of cereals. He probably ate slightly charred bread, although the burning may have had ritual significance rather than being an accident. Some mistletoe pollen was also found in the stomach, indicating that Lindow Man died in March or April. Archaeologists continue to consider what this simple meal might mean. Sophia Adams of the British Museum describes it as an unseasoned barley cake, a common Iron Age food. Some scholars, following the work of Anne Ross, suggest that burnt pieces of griddle cake may have been used in selection rituals similar to drawing lots. If so, the charred portion in Lindow Man's meal could signal that he was chosen for a specific role. Other researchers focus on the mixed seeds and plant fragments in the cake. Miranda Aldhouse-Green notes that the ingredients came from several locations, which may have been meant to represent control over a wider landscape or the area involved in the ritual. She also points out that the same evidence could mean something else, such as a plain or intentionally demeaning final meal. Mistletoe pollen provides another clue.
== Relevance to the origin of life == The Miller–Urey experiment was proof that the building blocks of life could be synthesized abiotically from gases, and introduced a new prebiotic chemistry framework through which to study the origin of life. Simulations of protein sequences present in the last universal common ancestor (LUCA), or the last shared ancestor of all extant species today, show an enrichment in simple amino acids that were available in the prebiotic environment according to Miller–Urey chemistry. This suggests that the genetic code from which all life evolved was rooted in a smaller suite of amino acids than those used today. Thus, while creationist arguments focus on the fact that Miller–Urey experiments have not generated all 22 genetically-encoded amino acids, this does not actually conflict with the evolutionary perspective on the origin of life.
=== Neurotransmitters === T3 may increase serotonin in the brain, in particular in the cerebral cortex, and down-regulate 5HT-2 receptors, based on studies in which T3 reversed learned helplessness in rats and physiological studies of the rat brain.
These drugs are expected to restore a normal libido in patients. Targeting acquired and generalized hypoactive sexual desire disorder (HSDD), improvement in sexual desire, and alleviation of psychological stress are to relieve the correlated symptoms. However, the treatments cannot cope with medically or psychiatrically related conditions, nor the effects from other medications.
Sources: en.wikipedia.org
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence corresponds to a fragment of a protein found in human gastric juice. It is studied mainly in preclinical research and is not an approved pharmaceutical product in major markets. Materials sold for laboratory use are typically labelled as research chemicals.
No medicines regulator in the United States or the European Union has approved BPC-157 as a therapeutic product. Presenting it as a drug or as a dietary supplement ingredient would generally not match its regulatory status. Availability as a research chemical does not imply clinical approval.
Published reports rest largely on animal models and cell culture rather than controlled human trials. Review articles describe the proposed mechanisms as incompletely understood. Conclusions about effects in humans therefore remain tentative.
The dry powder is the stable form and the dissolved form is comparatively fragile. Freezing a solution slows degradation but does not stop it, and repeated freezing and thawing adds further stress. Many laboratories therefore prepare small single-use portions rather than storing one large volume.